| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |